The blood-based samples for the original publication [1] were purchased from the Institut für Klinische Transfusionsmedizin Jena gGmbH (Jena, Germany). Thus, no ethics approval and informed consent are needed. However, the Institutional Review Board Statement of the paper should not be “Not applicable”, and it should be changed to a specific reason why the ethics approval can be waived.
A correction has been made to Institutional Review Board Statement:
Institutional Review Board Statement: The blood samples were purchased from the Institut für Klinische Transfusionsmedizin Jena gGmbH (Jena, Germany). All methods were performed in accordance with the relevant guidelines and regulations of the clinics of Universitätsklinikum Jena, thus the blood samples are exempt from the need for ethical approval.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Dwivedi, A.; Ryabchykov, O.; Liu, C.; Farnesi, E.; Schmidt, M.S.; Bocklitz, T.; Popp, J.; Cialla-May, D. SERS-Driven Ceftriaxone Detection in Blood Plasma: A Protein Precipitation Approach. Chemosensors 2024, 12, 213. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).